Ru2 not only decreased the expression of Nrf2 but also the downstream targets Nqo1 and HO1. However, research on the anti-cancer activities of other metal-based complexes against HCC is still in its infancy. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.